samsungbiologics 207940 Algorithm Investment Report

1. Performance Analysis of Algorithm (Separate) 207940 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2019.06 2019.09 2019.12 2020.03 2020.06 2020.09
IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep)
Sales 4,646 5,358 7,016 5,673 781 1,848 3,133 2,072 2,815 3,838 1,959
O-profit 660 557 917 711 -154 236 1,070 626 1,204 2,910 445
N-income -970 2,241 2,029 1,100 -134 441 2,090 501 1,204 3,318 725
O-rate 14.2 10.4 13.1 12.6 -19.7 12.8 34.2 30.2 42.8 75.8 29.3
N-rate -20.9 41.8 28.9 16.6 -17.2 23.9 66.7 24.2 42.7 86.5 37.8
ROE -2.4 5.4 4.7 2.5 -1.3 1.5 6.5 3.5 5.8 12.2 4.7
Debt-ratio 80.6 43.9 35.8 53.4 42.0 39.5 35.8 38.9 36.5 34.3 37.8
Quick-ratio 18.0 176.7 127.9 107.5 153.0 120.9 127.9 131.6 140.6 164.5 139.8
reserve-ratio 2,306.5 2,416.6 2,539.2 2,420.8 2,385.2 2,411.9 2,539.2 1,595.4 1,576.1 1,562.0 2,011.6
EPS -1,466 3,387 3,067 1,663 -203 667 3,159 757 1,819 5,015 1,095
BPS 60,100 62,805 65,813 62,906 62,013 62,683 65,813 42,134 38,355 34,915 58,161
Dividends 0 0 0 0
2020-06-11
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ -38 %
High mid ~ -46 %
Mid ~ -55 %
Low mid ~ -63 %
Low price ~ -72 %
Indication price Range Current stock price Company score
402,128 W 402,128 W 339,026 W
339,026 W 339,026 W 275,923 W Evaluation
465,231 W 465,231 W~ 402,128 W
747,000 W
44.2275,923 W 275,923 W 212,821 W
High price
Normal
212,821 W 212,821 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 43 3,119 738
212,821원
275,923원
339,026원
402,128원
465,231원
High price
747,000원
-72%
-63%
-55%
-46%
-38%
-80%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
100,000W
200,000W
300,000W
400,000W
500,000W
600,000W
700,000W
800,000W
Low price Low mid Mid High mid High price
Indication price chart (Separate)
Indication price
samsungbiologics
Gap
samsungbiologics

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (Separate) 207940 Date
Period
Gap
(Indication /
stock)
Color
2020-06-11
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
747,000 W High price 57.4 Normal 1,950,000 W
Suggested Purchase
Amount 726,740 W
Number of stocks
purchased 1
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 465,231 W 465,231 W~ ~ 402,128 W -38 % 274,127 W 1
High mid 402,128 W 402,128 W ~ 339,026 W -46 % 335,519 W 1
Mid 339,026 W 339,026 W ~ 275,923 W -55 % 396,910 W 1
Low mid 275,923 W 275,923 W ~ 212,821 W -63 % 458,301 W 2
low price 212,821 W 212,821 W ~ 0 W -72 % 519,692 W 2
2020.01.15 2020.02.14 2020.03.13 2020.04.10 2020.05.14 2020.06.11
22.1 31.5 47.4
Stock price rise
probability score
A Sector 53.3 44.9 50.9 49.9 45.1 46.8
57.4B Sector 44.6 38.3 49.9 49.9 17.9 47.9
Total average 49.0 41.6 39.4
30 % 34 %
2020.02.14 2020.03.13 2020.04.10 2020.05.14 2020.06.11
Total of
increase rate
Total score
A Sector -19 % 12 % -2 % -11 % 4 %
-8 % 44.7B Sector -16 % -37 % 44 % -179 % 63 %
Total average -18 % -6 % -78 %
-19%
12%
-2% -11%
4%
-16%
-37%
44%
-179%
63%
-18%
-6%
-78%
30% 34%
-200%
-150%
-100%
-50%
0%
50%
100%
2020.02.14 2020.03.13 2020.04.10 2020.05.14 2020.06.11
Increase rate of stock price rise
A sector
B sector
Total average
samsungbiologics
53
45
51 50
45 4745
38
28
50
18
4849
42 39
22
32
47
0
10
20
30
40
50
60
2020.01.15 2020.02.14 2020.03.13 2020.04.10 2020.05.14 2020.06.11
Stock price rise probability score
A sector
B sector
Total average

3. may
ded by
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374